Welltower Inc.

NYSE:WELL

REIT - Healthcare Facilities

Real Estate
$247.25 +0.21%

+$0.44 today

Market cap
$181.39B
Beta
0.78
P/E (TTM)
102.9
EPS (TTM)
$2.01
Dividend yield
1.43%
52W Low $148.97High $221.68

Volume 4.27M

Average 3.24M

WELL EBITDA

Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.

Welltower Inc.NYSE: WELL

EBITDA · Q3 FY2026 · quarter ended Sep 2026

EBITDA growth accelerates

Q3 FY2026 EBITDA of $1.29B rose 31.7% year over year, ahead of the -5.4% change in trailing-twelve-month EBITDA. Sequentially, it fell 2.9% from the prior quarter. Over 3 fiscal years it compounded at +4.2% a year.

Context

  • EBITDA amounted to 21.7% of revenue in FY2025, down 13.7 pp from a year earlier.
  • EBITDA increased in 2 of the last 3 fiscal years.

What to watch

Whether EBITDA reaches the consensus estimate from 5 analysts of $4.39B (+90.0%) for the fiscal year ending Dec 2026, a step up from the -16.8% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterSep 2026
$1.29B-2.9% QoQ
Last fiscal yearDec 2025
$2.31B-16.8% YoY
LTMSep 2026
$3.33B-5.4% YoY
EBITDA past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+31.7%+415.7%+384.0 pp
1 year-16.8%+90.0%+106.8 pp
3-year CAGR+4.2%+26.1%+21.8 pp
5-year CAGR+19.7%—
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA history

USD · from the income statement

Latest · FY2025
2.31B USD
Year-over-year change
-16.8%
4-year CAGR
+7.8%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA vs competitors

How WELL compares with its peers on the latest reported figures

  • WELL's LTM Sep 2026 EBITDA of $3.33B is the highest of the 11 companies compared; the peer median is $725.13M.
  • Its year-over-year change of -5.4% is the 10th highest of 11, against a peer median of +47.6%.
  • EBITDA amounts to 24.3% of revenue for WELL, versus a peer median of 83.8%.
WELL Competitors Peer median
EBITDA for WELL and competitors
Company Period LTM YoY 3-year CAGR% of revenue
WELLWelltower Inc.LTM Sep 2026$3.33B -5.4%+4.2%24.3%
VTRVentas, Inc.LTM Jun 2026$2.48B +27.0%+14.3%38.5%
DOCHealthpeak Properties, Inc.LTM Sep 2026$1.76B +15.8%+1.1%78.5%
OHIOmega Healthcare Investors, Inc.LTM Jun 2026$1.45B +41.6%+5.3%112.1%
MPTMedical Properties Trust, Inc.LTM Jun 2026$1.05B +979.1%-31.2%103.2%
NHINational Health Investors, Inc.LTM Sep 2026$851.29M +205.9%+16.4%186.2%
LTCLTC Properties, Inc.LTM Sep 2026$598.98M +449.6%+5.2%152.0%
CTRECareTrust REIT, Inc.LTM Sep 2026$547.75M +45.6%+85.1%89.0%
AHRAmerican Healthcare REIT, Inc.LTM Sep 2026$482.47M +49.6%+15.4%18.1%
SBRASabra Health Care REIT, Inc.LTM Jun 2026$390.9M -17.8%+28.2%45.5%
NHPBPNational Healthcare Properties, Inc.LTM Mar 2026$73.51M +495.0%+15.1%21.5%
Peer median (excluding WELL) $725.13M+47.6%+14.7%83.8%

Competitors are the stored peer set for WELL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue4.71B5.78B6.48B7.85B10.67B
Cost of Revenue2.77B3.56B3.95B4.83B6.49B
Gross Profit1.93B2.22B2.53B3.02B4.18B
Gross Margin41.1%38.4%39.1%38.5%39.2%
Research & Development00000
Selling, General & Admin126.73M150.39M179.09M235.49M1.75B
Operating Expenses1.17B1.47B1.59B1.88B3.82B
Depreciation & Amortization1.05B1.34B1.44B1.68B2.14B
EBITDA1.71B2.04B2.4B2.78B2.31B
EBITDA Margin36.4%35.3%37.1%35.4%21.7%
Operating Income763.36M746.22M940.45M1.15B355.17M
Operating Margin16.2%12.9%14.5%14.6%3.3%
Interest Income00000
Interest Expense489.85M529.52M607.85M574.26M651.96M
Other Income / Expenses(380.16M)(578.41M)(575.95M)(170.14M)599.55M
Income Before Tax383.19M167.82M364.5M975.56M954.72M
Pre-Tax Margin8.1%2.9%5.6%12.4%9.0%
Income Tax Expense8.71M7.25M6.36M2.7M(7.12M)
Net Income336.14M141.21M340.09M951.68M936.85M
Net Margin7.1%2.4%5.2%12.1%8.8%
EPS (Basic)0.790.310.661.581.41
EPS (Diluted)0.780.300.661.571.39
Weighted Avg Shares424.98M462.19M515.63M602.98M665.64M
Weighted Avg Shares (Diluted)426.84M465.16M518.7M608.75M679.52M

Welltower Inc.

NYSE:WELL

Intrinsic Alpha fair value

Locked

Current Price

$247.25

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.